Maraganore John Insider Trades

Insider Trading History

Track insider trading activity for Maraganore John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.17M 16,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$744k 16,000 shares
$46.47
$73.21
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $808k 21,850 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 21,850 shares
$10.95
$37.00
Beam Therapeutics
Beam Therapeutics BEAM
Director
Holding Value $995k 33,662 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$577k 33,662 shares
$17.15
$29.55
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.17M 16,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 16,000 shares
$31.20
$73.21
Beam Therapeutics
Beam Therapeutics BEAM
Director
Holding Value $683k 23,114 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 23,114 shares
$24.49
$29.55
ProKidney
ProKidney PROK
Director
Holding Value $83.3k 48,128 shares
Last Trade
Jun 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$508k 48,128 shares
$10.56
$1.73
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $879k 12,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 12,000 shares
$27.67
$73.21
Beam Therapeutics
Beam Therapeutics BEAM
Director
Holding Value $489k 16,532 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$568k 16,532 shares
$34.33
$29.55
Beam Therapeutics
Beam Therapeutics BEAM
Director
Holding Value $307k 10,391 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$578k 10,391 shares
$55.58
$29.55
ProKidney
ProKidney PROK
Director
Holding Value $1.06M 614,013 shares
Last Trade
Jul 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.73
ProKidney
ProKidney PROK
Director
Holding Value $1.06M 614,013 shares
Last Trade
Jul 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.73
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $811k 29,307 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$530k 29,307 shares
$18.09
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $811k 29,307 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$530k 29,307 shares
$18.09
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $138k 4,975 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 4,975 shares
$18.09
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $831k 30,028 shares
Last Trade
May 20, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.4k 1,585 shares
$21.10
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
May 20, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.4k 1,585 shares
$21.10
$27.68
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.76M 24,000 shares
Last Trade
Jan 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$951k 24,000 shares
$39.61
$73.21
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Chief Executive Officer
Holding Value $66.6M 227,663 shares
Last Trade
Dec 22, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.3k 319 shares
$186.02
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Chief Executive Officer
Holding Value $66.7M 227,982 shares
Last Trade
Dec 22, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$381 2 shares
$190.50
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Chief Executive Officer
Holding Value $66.7M 227,984 shares
Last Trade
Dec 22, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.19M 6,315 shares
$189.13
$292.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up